We are live on ! Find out more
TYRA icon

Tyra Biosciences
TYRA

45 hedge funds and large institutions have $494M invested in Tyra Biosciences in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

211% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 9

73% more funds holding

Funds holding: 26 → 45 (+19)

23.92% more ownership

Funds ownership: 61.31% → 85.23% (+24%)

8% more capital invested

Capital invested by funds: $457M → $494M (+$37.4M)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

Holders
45
Holders Change
+19
Holders Change %
+73.08%
% of All Funds
0.69%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.06%
New
28
Increased
7
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$31M
2
BlackRock
BlackRock
New York
+$11.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.1M
5
BI
BVF Inc
California
+$3.54M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$11M
2
LGM
Logos Global Management
California
-$10.5M
3
Jennison Associates
Jennison Associates
New York
-$8.24M
4
PA
Perceptive Advisors
New York
-$6.24M
5
CAM
Cormorant Asset Management
Massachusetts
-$4.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$1.12M +$1.58M +79,347 New
Citadel Advisors
27
Citadel Advisors
Florida
$1.1M +$1.56M +78,313 New
Morgan Stanley
28
Morgan Stanley
New York
$503K +$710K +35,748 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$289K +$409K +20,575 New
N
30
Nuveen
North Carolina
$259K +$366K +18,400 New
HF
31
HRT Financial
New York
$253K -$274K -13,806 -43%
OWP
32
Old Well Partners
North Carolina
$148K +$209K +10,500 New
Deutsche Bank
33
Deutsche Bank
Germany
$104K +$147K +7,389 New
Wells Fargo
34
Wells Fargo
California
$99K +$140K +7,051 New
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$94K +$132K +6,665 New
AIG
36
American International Group
New York
$91K +$128K +6,462 New
Bank of America
37
Bank of America
North Carolina
$80K +$96.2K +4,840 +547%
UBS Group
38
UBS Group
Switzerland
$77K +$109K +5,473 New
Citigroup
39
Citigroup
New York
$45K +$54.1K +2,725 +619%
SO
40
STRS Ohio
Ohio
$39K +$55.6K +2,800 New
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$35K +$49.5K +2,491 New
Legal & General Group
42
Legal & General Group
United Kingdom
$16K +$22.4K +1,126 New
TRCT
43
Tower Research Capital (TRC)
New York
$14K +$19.1K +963 New
AIP
44
Ameritas Investment Partners
Nebraska
$13K +$18.7K +940 New
Northwestern Mutual Wealth Management
45
Northwestern Mutual Wealth Management
Wisconsin
$4K +$5.96K +300 New
DM
46
Deerfield Management
New York
– -$11M -625,000 Closed
Jennison Associates
47
Jennison Associates
New York
– -$8.24M -468,750 Closed
Goldman Sachs
48
Goldman Sachs
New York
– -$3.65M -207,283 Closed
LP
49
LMR Partners
United Kingdom
– -$950K -54,000 Closed
PCM
50
Pinz Capital Management
New York
– -$487K -27,700 Closed
1
2
3

TYRA Hedge Fund Activity: Q4 2021 in Review

45 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tyra Biosciences (TYRA) for Q4 2021, worth a combined $494M — up 8.2% from $457M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new TYRA positions and 9 closed out — a net gain of 19 holders — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $31M. The largest seller was Deerfield Management, exiting entirely with an estimated $11M sold.

  • 45 institutional investors held Tyra Biosciences (TYRA) as of Q4 2021, up from 26 in Q3 2021.
  • Funds reported $494M of Tyra Biosciences stock for Q4 2021, up 8.2% quarter-over-quarter.
  • 28 funds opened new Tyra Biosciences positions in Q4 2021 and 9 closed out, a net change of +19 holders.
  • The largest Tyra Biosciences buyer in Q4 2021 was Fidelity Investments, an estimated $31M added.
  • The largest Tyra Biosciences seller in Q4 2021 was Deerfield Management, an estimated $11M sold.

Based on aggregated 13F filings for Q4 2021.